Gujarat Terce Laboratories Limited (BOM:524314)

India flag India · Delayed Price · Currency is INR
53.00
+1.85 (3.62%)
At close: Jun 27, 2025
13.10%
Market Cap 382.81M
Revenue (ttm) 501.95M
Net Income (ttm) -9.79M
Shares Out 7.42M
EPS (ttm) -1.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,422
Average Volume 6,768
Open 49.65
Previous Close 51.15
Day's Range 49.65 - 53.99
52-Week Range 44.52 - 94.90
Beta 0.62
RSI 43.04
Earnings Date Aug 8, 2025

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company’s products include branded generic pharmaceutical covering various therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides its products in various forms, including tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, and Aziter brands. Gujarat Ter... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 286
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524314
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.